Form 6-K Rosetta Genomics Ltd. For: Dec 01

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. HUM
8. KTOS
9. NVDA
10. CSCO

Go back to Form 6-K Rosetta Genomics Ltd. For: Dec 01

Rosetta Genomics (ROSG) Reports Q3 EPS of $0.27

December 1, 2015 7:55 AM EST

Rosetta Genomics (NASDAQ: ROSG) reported Q3 EPS of $0.27, versus $0.29 reported last year. Revenue for the quarter came in at $2.43 million, versus $273 thousand reported last year.

Management Commentary

During recent months we continued to make meaningful progress integrating the PersonalizeDx acquisition, growing top-line results, expanding our high-value molecular diagnostics offerings with important product launches, upgrading our sales and reimbursement infrastructure and strengthening our balance sheet, stated Kenneth A. Berlin, President and Chief Executive Officer of Rosetta Genomics.

The third quarter of 2015 was the first full quarter of PersonalizeDx... More